Earnings Call · Q2 FY2022·2022-08-15

Q2 22EPS -26.67%·Rev n/aQ1 22EPS -15.38%·Rev n/aQ4 21EPS +15.00%·Rev n/aQ3 21EPS +26.71%·Rev n/a⚠ consensus missing

BRAINSTORM CELL THERAPEUTICS INC. BCLI

Tom Galassi — Investor Relations or Analyst

Chaim Lebovits — Chief Executive Officer

Stacy Lindborg — Chief Medical Officer

Ralph Kern — Chief Scientific Officer

Alla Patlis — Chief Financial Officer

−1.4%1d on move date−1.8% vs SPY3d+10.0%5d+8.0%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more BCLI calls or request research access.

More BCLI calls Browse calls Request research access